Enhanced passive safety surveillance of Vaxigrip (trivalent inactivated split virion influenza vaccine, IM route) and Intanza 15 (trivalent inactivated split virion influenza vaccine, ID route) vaccines in Europe during the influenza season 2015/16
Phase of Trial: Phase IV
Latest Information Update: 19 Jul 2016
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors sanofi pasteur MSD
- 13 Jul 2016 Status changed from active, no longer recruiting to completed.
- 28 Jan 2016 According to United Kingdom Clinical Research Network record, status changed from recruiting to active, no longer recruiting.
- 27 Nov 2015 New trial record